Ahzantive

Ahzantive is an intravitreal injection containing aflibercept, used to treat eye conditions like wet age-related macular degeneration. This medication helps slow vision loss by targeting vascular growth factors.

Ahzantive is primarily used for intravitreal administration to manage conditions like wet age-related macular degeneration. It works by inhibiting vascular endothelial growth factor (VEGF), which can help reduce abnormal blood vessel growth in the retina. Patients often wonder, 'What is Ahzantive used for?'—it is designed to slow vision loss and, in some cases, improve vision in specific eye conditions.

Common effects of Ahzantive may include eye redness, pain, or increased floaters. Some patients might experience temporary vision changes or eye discomfort following the injection. These effects are generally mild and resolve on their own, but persistent issues should be discussed with a healthcare provider.

Ahzantive should only be administered by a qualified healthcare professional. Patients with a history of eye infections or severe eye trauma should inform their doctor before treatment. Proper hygiene and follow-up care are essential to minimize risks associated with intravitreal injections.

Ahzantive may interact with other medications, particularly those affecting blood clotting or immune response. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and certain foods may also influence the effectiveness or safety of the treatment.